Metraipolis › archive › dc_208cb3bd48d6

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses — Europe PMC PMID:42256206

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42256206
DOI
10.1016/j.omton.2026.201230
License (as archived)
solo-consultazione
Archived
2026-11-02T12:46:49.224Z
SHA-256 of the archived text
a1ad509e4abd058ff208b8db2494d42552be77569c62476e7903042ab75d31a4
Stable URL of this page
https://metraipolis.com/documento/dc_208cb3bd48d6

How to cite

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses — Europe PMC PMID:42256206 — Europe PMC (en), https://europepmc.org/article/MED/42256206 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_208cb3bd48d6 (Metraipolis archive dc_208cb3bd48d6, sha256 a1ad509e4abd058ff208b8db2494d42552be77569c62476e7903042ab75d31a4)
BibTeX
@misc{dc208cb3bd48d6,
  title = {CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses — Europe PMC PMID:42256206},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42256206},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_208cb3bd48d6; sha256 a1ad509e4abd058ff208b8db2494d42552be77569c62476e7903042ab75d31a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256206. Agents can read the archived copy with the MCP tool read_document.